Cas no 178101-87-6 (L-1-13CXylose)
L-1-13CXylose Chemical and Physical Properties
Names and Identifiers
-
- L-Xylose-1-13C (9CI)
- L-[1-13C]XYLOSE
- (3S,4R,5S)-(213C)oxane-2,3,4,5-tetrol
- 178101-87-6
- L-Xylose-1-13c(9ci)
- L-1-13CXylose
-
- Inchi: 1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5?/m0/s1/i5+1
- InChI Key: SRBFZHDQGSBBOR-LBGCCOHZSA-N
- SMILES: O1C[C@@H]([C@H]([C@@H]([13CH]1O)O)O)O
Computed Properties
- Exact Mass: 151.05617825g/mol
- Monoisotopic Mass: 151.05617825g/mol
- Isotope Atom Count: 1
- Hydrogen Bond Donor Count: 4
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 10
- Rotatable Bond Count: 0
- Complexity: 117
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 3
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -2.5
- Topological Polar Surface Area: 90.2?2
L-1-13CXylose Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | X750702-5mg |
L-[1-13C]Xylose |
178101-87-6 | 5mg |
$155.00 | 2023-05-17 | ||
| TRC | X750702-50mg |
L-[1-13C]Xylose |
178101-87-6 | 50mg |
$1206.00 | 2023-05-17 | ||
| A2B Chem LLC | AE84402-250mg |
L-[1-13C]XYLOSE |
178101-87-6 | 250mg |
$597.00 | 2024-04-20 | ||
| A2B Chem LLC | AE84402-500mg |
L-[1-13C]XYLOSE |
178101-87-6 | 500mg |
$1003.00 | 2024-04-20 | ||
| A2B Chem LLC | AE84402-1g |
L-[1-13C]XYLOSE |
178101-87-6 | 1g |
$1791.00 | 2024-04-20 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-475038-5mg |
L-[1-13C]Xylose, |
178101-87-6 | 5mg |
¥2256.00 | 2023-09-05 | ||
| Omicron Biochemicals | XYL-010-0.25g |
L-[1-13C]xylose |
178101-87-6 | 0.25g |
$510 | 2025-02-19 | ||
| Omicron Biochemicals | XYL-010-0.50g |
L-[1-13C]xylose |
178101-87-6 | 0.50g |
$895 | 2025-02-19 | ||
| Omicron Biochemicals | XYL-010-1.0g |
L-[1-13C]xylose |
178101-87-6 | 1.0g |
$1630 | 2025-02-19 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-475038-5 mg |
L-[1-13C]Xylose, |
178101-87-6 | 5mg |
¥2,256.00 | 2023-07-11 |
L-1-13CXylose Related Literature
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
Additional information on L-1-13CXylose
Introduction to L-1-13CXylose (CAS No. 178101-87-6)
L-1-13CXylose, identified by the chemical abstracts service number 178101-87-6, is a specialized oligosaccharide derivative that has garnered significant attention in the field of biochemical research and pharmaceutical development. This compound, a modified form of xylose, exhibits unique structural and functional properties that make it a promising candidate for various applications, particularly in the context of glycoscience and metabolic engineering.
The molecular structure of L-1-13CXylose incorporates a carbon-13 labeled xylose backbone, which is achieved through advanced chemical synthesis techniques. This labeling not only provides a means for tracing metabolic pathways but also enhances the compound's utility in nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry studies. The carbon-13 isotope allows researchers to monitor the degradation and utilization of L-1-13CXylose with high precision, offering insights into its role in cellular processes.
In recent years, the study of oligosaccharides like L-1-13CXylose has been propelled by advancements in glycobiology, where these compounds play a crucial role in cell signaling, immune responses, and disease mechanisms. The modified xylose structure of L-1-13CXylose has been found to influence glycosylation patterns, which are critical for the proper folding and function of proteins. This has opened up new avenues for therapeutic interventions in conditions related to glycosylation disorders.
One of the most compelling applications of L-1-13CXylose is in the field of drug delivery systems. The compound's ability to act as a substrate for enzymes involved in carbohydrate metabolism makes it an ideal candidate for targeted drug delivery. By incorporating therapeutic agents into L-1-13CXylose conjugates, researchers can design molecules that release their payload in specific cellular compartments, thereby improving bioavailability and reducing side effects. This approach has shown promise in preclinical trials for treating inflammatory diseases and cancer.
The synthesis of L-1-13CXylose involves a multi-step process that requires precise control over reaction conditions to ensure high yield and purity. Researchers have developed novel catalytic methods that minimize byproduct formation, making the production process more efficient. Additionally, green chemistry principles have been applied to reduce the environmental impact of synthesizing this compound. These advancements not only make L-1-13CXylose more accessible but also align with global efforts to promote sustainable chemical manufacturing.
Recent studies have also explored the potential of L-1-13CXylose as a biomarker for metabolic diseases. By tracking the incorporation of carbon-13 labeled xylose into cellular components, researchers can gain valuable insights into metabolic pathways affected by conditions such as diabetes and obesity. This has implications for both diagnostic tools and therapeutic strategies aimed at modulating these pathways.
The role of L-1-13CXylose in agricultural biotechnology is another emerging area of interest. As a plant-derived sugar derivative, it can be used to enhance plant growth and resistance to pathogens. Experiments have shown that when applied as a soil amendment or foliar spray, L-1-13CXylose can stimulate root development and improve nutrient uptake. This has potential applications in sustainable agriculture, where optimizing plant health is crucial for increasing crop yields without relying heavily on synthetic fertilizers.
From a commercial perspective, the demand for specialized oligosaccharides like L-1-13CXylose is expected to grow as industries recognize their multifunctional applications. Companies involved in biochemical research are investing in large-scale production facilities to meet this demand. The compound's versatility makes it valuable not only in pharmaceuticals but also in food science, cosmetics, and industrial biotechnology.
The future research directions for L-1-13CXylose include exploring its potential in gene therapy and regenerative medicine. The compound's ability to interact with biological molecules suggests that it could be used to deliver therapeutic genes or promote tissue regeneration. Additionally, studying its interactions with microorganisms may lead to novel applications in probiotics and gut health research.
In conclusion, L-1-13CXylose (CAS No. 178101-87-6) represents a significant advancement in biochemical research with wide-ranging applications across multiple industries. Its unique structural features and functional properties make it an invaluable tool for studying metabolic processes, developing new drug delivery systems, and enhancing agricultural practices. As research continues to uncover new possibilities for this compound, its importance is likely to grow even further.
178101-87-6 (L-1-13CXylose) Related Products
- 9004-67-5(Methyl cellulose)
- 58-86-6(D(+)-Xylose)
- 97-30-3(Methyl a-D-Glucopyranoside)
- 9004-65-3(Hydroxypropyl methyl cellulose)
- 6155-35-7(α-L-Rhamnose monohydrate)
- 9005-25-8(Cornstarch)
- 641-74-7((3R,3aR,6R,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol)
- 69-79-4((2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-{(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yloxy}hexanal)
- 63-42-3(Lactose)
- 585-88-6(Maltitol)